1 year return (CAGR)
-93.62%
Oncternal Therapeutics Inc Exchange (NASDAQ, USD)
ONCT
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-70.25%
5 year return (CAGR)
-60.03%
10 year return (CAGR)
-53.10%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.56M
Price/Sales
0.93
Ent value
-5.07M
Price/Book
0.17
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-43.36%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.53 |
| Daily high | 0.53 |
| Daily low | 0.53 |
| Daily Volume | 0K |
| 1y analyst estimate | 2.00 |
| Beta | 1.33 |
| EPS (TTM) | -11.68 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ONCT | S&P500 | |
| Current price drop from All-time high | -100.00% | -9.56% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 29 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -77.32% | -10.68% |
| Avg time to new high | 172 days | 12 days |
| Max time to new high | 4533 days | 1805 days |
News
No items found